Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Syngene International announces extension of collaboration with Amgen Contract extended until 2026
Under the extended contract, the dedicated R&D centre, ‘Syngene Amgen Research and Development Center’ (SARC), will continue…
Aragen acquires Intox
Strengthens discovery-to-development integrated platform with the addition of GLP-certified safety assessment capabilities
Panel Discussion: Optimising FR&D to expedite regulatory compliance
FDD Conclave 2021 | Day 1 | 16th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference
Session by Dr Ranjit Barshikar, CEO-QbD International; United Nations Adviser – Geneva
FDD Conclave 2021 | Day 1 | 16th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference
Session by Uwe Killeman, Field Marketing Manager – Particle Counting & Characterization…
FDD Conclave 2021 | Day 1 | 16th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference
Panel Discussion: The pandemic effect on FDD
FDD Conclave 2021 | Day 1 | 16th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference
Session by Prabhaharan Sankaran, Technical Account Specialist, West Pharmaceutical Services
FDD Conclave 2021 | Day 1 | 16th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference
Session by Suresh Pareek, MD, Ideal Cures
FDD Conclave 2021 | Day 1 | 16th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference
Special Address: Ravi Udaya Bhaskar, Director-General, Pharmexcil
FDD Conclave 2021 | Day 1 | 16th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference
Zydus receives Orphan Drug Designation from US FDA for malaria treatment
The Orphan Drug Designation provides up to seven years of marketing exclusivity in the US